- Home
- SHPH
as 07-26-2024 4:00pm EST
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | GAITHERSBURG |
| Market Cap: | 7.5M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 734.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $0.94 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Shuttle Pharmaceuticals Holdings Inc. (SHPH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Jacobs Bette | SHPH | Director | Dec 13 '23 | Sell | $0.46 | 4,157 | $1,925.52 | 27,064 | SEC Form 4 |
| Brown Milton | SHPH | Director | Dec 13 '23 | Sell | $0.46 | 2,921 | $1,353.01 | 1,094,610 | SEC Form 4 |
| Senanayake Chris | SHPH | Director | Dec 29 '22 | Sell | $1.61 | 1,626 | $2,609.73 | 2,791 | SEC Form 4 |
Latest Shuttle Pharmaceuticals Holdings Inc. News
SHPH Breaking Stock News: Dive into SHPH Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
MT Newswires
a month ago
Shuttle Pharmaceuticals Names Timothy Lorber as Chief Financial Officer
GlobeNewswire
a month ago
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
GlobeNewswire
2 months ago
Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
GlobeNewswire
2 months ago
Shuttle Pharma Provides First Quarter 2024 Corporate Update
ACCESSWIRE
3 months ago
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
GlobeNewswire
3 months ago
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
GlobeNewswire
4 months ago
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
Compare SHPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SHPH Shuttle Pharmaceuticals Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.